Interestingly, longitudinal study showed that chemokine serum levels (IP-10, MCP-1, and MIP-3B) in SLE patients change with flares and remission periods, commensurately with SLEDAI score. The gene discussed is CCL2; the disease is systemic lupus erythematosus.